Security key
00973N102
Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ)
CUSIP: 00973N102
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 506,064
- Total 13F value
- $2,329
- Share change
- -20,627,553
- SEC-reported price per share
- $0.00
- Number of holders
- 6
- Value change
- -$1,774,940
- Number of buys
- 1
- Number of sells
- 68
- Shares outstanding
- 53,401,149
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
6
Top holders
6
AKTSQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Aktis Oncology, Inc. SEC filings
Aktis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00973N102
Recent filing periods:
Ownership snapshot
Top reported holders of AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 6%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
6%
Taylor Frigon Capital Management LLC
4.8%
SILVERBACK ASSET MANAGEMENT LLC
4.8%
CITADEL ADVISORS LLC
3.9%
Senvest Management, LLC
2.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
6%
|
$290,289
3,225,431 shares
|
— | 30 Sep 2024 |
| Taylor Frigon Capital Management LLC |
13F
Company
|
4.8%
|
$229,919
2,568,927 shares
|
— | 30 Sep 2024 |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
Company
|
4.8%
|
$227,097
2,537,400 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.9%
|
$187,545
2,095,467 shares
|
— | 30 Sep 2024 |
| Senvest Management, LLC |
13F
Company
|
2.8%
|
$134,250
1,500,000 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
2.3%
|
$107,899
1,205,574 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
506,064
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
74
Q4 2024 holders
6
Holder diff
-68
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend